Surmodics reported $93.04M in Current Assets for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Align Technology ALGN:US $ 2115.55M 266.02M
Anika Therapeutics ANIK:US $ 173.47M 3.91M
Arrowhead Research ARWR:US $ 586.76M 263.04M
Baxter International BAX:US $ 7856M 555M
Bioscrip BIOS:US $ 664.73M 7.72M
Cryolife CRY:US $ 235.68M 1.09M
Edap Tms EDAP:US $ 43.56M 1.84M
Edwards Lifesciences EW:US $ 3069.2M 21.8M
Genmark Diagnostics GNMK:US $ 172.96M 2.95M
Haemonetics HAE:US $ 693.55M 25.2M
Heron Therapeutics HRTX:US $ 272.29M 41.91M
Merit Medical Systems MMSI:US $ 438.49M 8.78M
Mesa Laboratories MLAB:US $ 303.75M 8.47M
Nektar Therapeutics NKTR:US $ 1099.05M 38.95M
Oxford Immunotec Global OXFD:US $ 188.37M 1.42M
Providence Service PRSC:US $ 537.23M 110.62M
Stryker SYK:US $ 8979M 728M
Surmodics SRDX:US $ 93.04M 12.18M
Trinity Biotech TRIB:US $ 87.61M 4.31M